A. Chari Et Al. , "Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy," ADVANCES IN THERAPY , vol.38, no.2, pp.1328-1341, 2021
Chari, A. Et Al. 2021. Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy. ADVANCES IN THERAPY , vol.38, no.2 , 1328-1341.
Chari, A., Munder, M., Weisel, K., Jenner, M., Bygrave, C., Petrucci, M. T., ... Boccadoro, M.(2021). Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy. ADVANCES IN THERAPY , vol.38, no.2, 1328-1341.
Chari, Ajai Et Al. "Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy," ADVANCES IN THERAPY , vol.38, no.2, 1328-1341, 2021
Chari, Ajai Et Al. "Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy." ADVANCES IN THERAPY , vol.38, no.2, pp.1328-1341, 2021
Chari, A. Et Al. (2021) . "Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy." ADVANCES IN THERAPY , vol.38, no.2, pp.1328-1341.
@article{article, author={Ajai Chari Et Al. }, title={Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy}, journal={ADVANCES IN THERAPY}, year=2021, pages={1328-1341} }